Friday, 19 October 2018

Accenture named a leader in Life Sciences R&D BPO Services

13 July 2018 | News

This is the third consecutive time Accenture Life Sciences has achieved this prestigious ranking.

Accenture has been named a Leader in an IDC Health Insights IDC MarketScape vendor assessment covering business process outsourcing (BPO) across the life sciences research and development (R&D) industry. This is the third consecutive time Accenture Life Sciences has achieved this prestigious ranking. 

The report, “IDC MarketScape: Worldwide Life Science R&D BPO 2018 Vendor Assessment" examines the current life sciences R&D BPO landscape, including industry and market trends, comparing major vendors against the criteria most important for life sciences companies to consider when selecting a service provider.

Alan Louie, Ph.D, research director for IDC Health Insights Life Sciences practice, notes in his report, “Accenture has extensive experience working with life science companies across all three sections of the industry: pharmaceutical, biotech, and medical devices. Building on an aggressive growth and acquisition strategy, Accenture has diversified significantly beyond its traditional big pharma focus and has grown its presence among emerging and mid-tier life science companies in recent years. Relative to other vendors discussed in this study, and based on feedback from multiple customer references, Accenture received high marks for transparent integration into client teams, working as a vested partner, and helping the client improve operational efficiencies across a widening portfolio of efforts.”

Kevin Julian, senior managing director in Accenture’s Life Sciences practice, said, “This leadership positioning in the IDC MarketScape emphasizes our focus on providing best-in-class solutions to top global and emerging pharmaceutical, biotech and medical device companies. We’re pleased to be recognized for the third consecutive time by IDC as a high-quality BPO service provider, demonstrating the breadth of our understanding of this dynamic industry across company-specific, strategic and tactical levels.”

In naming Accenture Life Sciences as a Leader, the IDC MarketScape looked at:

  • Breadth of services offered, depth of related project experience, and number of customers Accenture serves;
  • Geographical footprint and global delivery capabilities, level of priority and focus by Accenture on the life sciences R&D sector, and the pace of investment in related life sciences capabilities;
  • Life sciences' industry-specific expertise, corporate financial stability, and ability to accommodate different types and sizes of life sciences clients;
  • Customer references to examine vendor capabilities surrounding project management, IT technical skills, account management, and overall value delivery to clients.

For the purposes of this analysis, IDC Health Insights divided potential key measures for success into two primary categories: capabilities and strategies. The assessment includes client references.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Click Here!




Survey Box

Can blockchain help cease fake drug distribution in India?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls